![](/img/cover-not-exists.png)
In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections
Andrew P. Desbois, Curtis G. Gemmell, Peter J. CooteVolume:
35
Year:
2010
Language:
english
DOI:
10.1016/j.ijantimicag.2010.01.016
File:
PDF, 291 KB
english, 2010